Park Jonas J-H, Emmerling Oliver, Westhofen Martin
Department of Otolaryngology and Head and Neck Surgery, University Hospital Aachen, RWTH Aachen University, Pauwelsstrasse 30, Aachen, Germany.
Acta Otolaryngol. 2012 Feb;132(2):218-24. doi: 10.3109/00016489.2011.636377. Epub 2011 Dec 27.
No impact of neck ultrasound on the detection rate of neck recurrences of head and neck squamous cell carcinomas (HNSCCs) was seen. The outcome of salvage therapy was not influenced by close neck ultrasound monitoring during follow-up. Tendencies of earlier detection of neck recurrences were noticed.
Neck ultrasound is more feasible for frequent application than computed tomography, while having comparable sensitivity and specificity in detecting neck metastasis. Before this study the effect of neck ultrasound on salvage therapy of neck recurrences when used in short defined intervals during follow-up was unknown.
A total of 140 patients with primarily surgically treated HNSCC were enrolled in a follow-up program with defined close time intervals. Neck ultrasound was applied during every follow-up visit. Recurrence rate, survival rate, and outcome of salvage therapy were determined.
Overall recurrences occurred in 35.0% of patients. Local, regional, and distant recurrences were found in 11.4%, 7.9%, and 15.7%. Hypopharyngeal carcinoma and advanced staged tumor showed highest recurrence rates. In all, 24.5% of all recurrences were treated successfully by salvage therapy. Resection of local, regional, and distant recurrences resulted in 3-year survival rates of 43.8%, 36.4%, and 4.5%. The outcome of secondary therapy worsened with advancing initial primary tumor stage.
未发现颈部超声对头颈部鳞状细胞癌(HNSCC)颈部复发的检出率有影响。随访期间密切的颈部超声监测对挽救治疗的结果没有影响。但观察到有更早发现颈部复发的趋势。
与计算机断层扫描相比,颈部超声更适合频繁应用,且在检测颈部转移方面具有相当的敏感性和特异性。在本研究之前,尚不清楚在随访期间以较短的固定间隔使用颈部超声对颈部复发挽救治疗的效果。
共有140例主要接受手术治疗的HNSCC患者纳入了一个具有固定紧密时间间隔的随访项目。每次随访时均进行颈部超声检查。确定复发率、生存率和挽救治疗的结果。
35.0%的患者出现总体复发。局部、区域和远处复发分别占11.4%、7.9%和15.7%。下咽癌和晚期肿瘤的复发率最高。所有复发患者中,24.5%通过挽救治疗成功治愈。局部、区域和远处复发的切除术后3年生存率分别为43.8%、36.4%和4.5%。二次治疗的结果随着初始原发肿瘤分期的进展而恶化。